ABSTRACT
Background
Iron‐limited erythropoiesis (ILE) is a common condition in dogs and cats, which can lead to anemia; therefore, monitoring with erythrocyte and reticulocyte indices is recommended.
Objectives
To compare the values of mean corpuscular volume (MCV), mean reticulocyte volume (MCVr), and reticulocyte hemoglobin content (CHr) in dogs and cats with ILE.
Methods
Systemative review and meta‐analysis. We conducted a systematic search using PRISMA criteria in PubMed, ScienceDirect, and Google Scholar up to 2024. It focused on erythrocyte and reticulocyte indices, such as MCV, MCVr, and CHr, in dogs and cats with ILE.
Results
This meta‐analysis included eight articles. For dogs, the random effect sizes were 2.86 (0.55–5.18) for MCV, 2.18 (0.87–3.58) for MCVr, and 4.73 (1.37–8.08) for CHr. For cats, the effect sizes were 0.85 (0.19–1.5) for MCV, 3.45 (0.49–6.41) for MCVr, and 2.51 (0.29–4.74) for CHr. The analysis revealed I 2 values of 97%, 94.3%, and 98.2% in dogs, and 63.1%, 93%, and 95.1% in cats, for MCV, MCVr, and CHr, respectively. The overall random effects were 1.98 for MCV, 2.54 for MCVr, and 3.87 for CHr.
Conclusion and Clinical Importance
The findings revealed significant differences in reticulocyte indices, MCVr in cats, and CHr in dogs between the ILE‐affected and the healthy groups. Considerable variability among studies indicates caution in generalizing findings and makes conclusions less definitive.
Keywords: cats, CHr, dogs, iron‐limited erythropoiesis, MCVr, meta‐analysis
Abbreviations
- 95% CI
95% confidence interval
- CHCMr
mean corpuscular hemoglobin concentration of reticulocytes
- CHr
reticulocyte hemoglobin content
- ES
estimated
- FeDef
Fe deficiency
- ID
iron deficiency
- IDA
iron deficiency anemia
- ILE
iron‐limited erythropoiesis
- MCH
mean corpuscular hemoglobin
- MCHC
mean corpuscular hemoglobin concentration
- MCV
mean corpuscular volume
- MCVr
mean reticulocyte volume
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta‐Analyses
- RDW
red cell distribution width
- RI
reference interval
- SD
standard deviation
1. Introduction
Iron is an essential element in the bodies of vertebrates that plays a fundamental role in the structure and function of hemoglobin [1, 2, 3]. Iron‐limited erythropoiesis (ILE) results from a negative iron imbalance [1, 4]. In dogs and cats, ILE due to malnutrition and malabsorption occurs rarely, and the most common causes of ILE in animals are chronic bleeding, portosystemic shunt, inflammatory diseases, chronic kidney disease (CKD), and immune‐mediated hemolytic anemia (IMHA) [5, 6, 7].
Traditional red blood cell (RBC) indices, such as mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), mainly characterize mature erythrocytes [8, 9, 10]. Given the long lifespan of erythrocytes (120 days in humans and dogs and 70 days in cats), ILE needs to persist for weeks to months before changes in these indices become apparent. As a result, conventional RBC indices are relatively insensitive during the early stages of iron deficiency (ID), meaning that acute or subacute cases of ILE can often go unrecognized [1, 8, 11].
The reticulocyte indices commonly reported in companion animal literature include the reticulocyte hemoglobin content (CHr), mean reticulocyte volume (MCVr), and the mean corpuscular hemoglobin concentration of reticulocytes (CHCMr) [12]. The reference intervals (RIs) of these indices in canines have been well‐documented for ADVIA hematology analyzers [1]. Some studies have demonstrated promising results and firmly suggested the reliability of these indices in identifying ILE [1]. However, other research has reported an inability of these reticulocyte indices to distinguish absolute from functional ILE and has found similar abnormalities present in dogs with other conditions [13].
Recently, reticulocyte indices have been used to reflect the functional iron available for erythropoiesis over the past 2 to 4 days [5, 8, 11]. Low CHr and MCVr levels are associated with hematologic and biochemical indicators of ILE [1, 5]. Additionally, reticulocyte indices are promising in detecting functional ILE, even before the development of overt microcytosis, which helps us detect early stages of ILE even before anemia [8, 10, 12]. Despite evidence showing that reticulocyte indices, particularly CHr, can identify early stages of ILE, neither CHr nor iron metabolism variables such as serum iron concentration and total iron‐binding capacity (TIBC) can reliably distinguish between underlying diseases that ultimately lead to ILE [14]. This is due to overlapping results across different disease groups, the lack of a proper gold standard (such as iron staining or hemosiderin in cat bone marrow samples) [15], and the absence of other biochemical tests (such as ferritin and soluble transferrin receptor) in veterinary medicine [5]. Early diagnosis of ILE might improve treatment efficiency by providing early opportunities for interventional procedures, thereby improving the effectiveness of treatment.
Considering the lack of systematic reviews regarding the evaluation of reticulocyte indices in dogs and cats affected by ILE, along with the differing objectives in previous studies, this study was conducted as a systematic review and meta‐analysis aimed at examining the impact of ILE on the indices of MCV, MCVr, and CHr. We have thoroughly analyzed numerous articles and data to support our conclusion. We found multiple articles discussing the impact of ILE on erythrocyte and reticulocyte indices in dogs and cats, either narratively or statistically [5, 6, 7, 8, 10, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24], and finally, used those with enough information. In other words, the investigations have been summarized to demonstrate their value in characterizing ILE, and reticulocyte indices also receive attention in both veterinary and human medicine.
2. Methods
2.1. Systematic Review Protocol Development
The meta‐analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines [25]. Although this review does not evaluate an intervention, the primary research question was structured using the PECO framework, which is appropriate for exposure‐focused systematic reviews. Specifically, P (population) refers to dogs and cats, E (exposure) refers to the presence of ILE, c (comparison) refers to healthy controls, and O (outcome) refers to changes in erythrocyte and reticulocyte indices (MCV, MCVr, and CHr). The primary question of this review was: Can erythrocyte and reticulocyte indices, such as MCV, MCVr, and CHr, be utilized in monitoring ILE in dogs and cats, based on the current evidence? The research question was raised and revised in several stages, and initial investigations were conducted in existing scientific resources. Given the use of previously published data, this study did not require ethical approval.
2.2. Search Strategy
Two authors (Y.H. and P.A.) independently reviewed the articles. Both authors deemed the articles suitable for inclusion in the meta‐analysis, and the study included only articles that were considered appropriate by both authors. Articles deemed suitable by only one author were referred to a third person (MA) for the final decision, and their opinion was used as the criterion. An extensive literature review evaluated the potential of MCV, MCVr, and CHr biomarkers for characterizing ID, iron deficiency anemia (IDA), or ILE in dogs and cats using PubMed, ScienceDirect, and Google Scholar. The search incorporated various terms, including “Iron deficiency” OR “Iron deficiency anemia” OR “Iron‐limited erythropoiesis” AND dog OR cat OR “canine” OR “feline” AND “Mean corpuscular volume” OR “Mean reticulocyte volume” OR “Reticulocyte hemoglobin content.” Full‐text research articles that described the clinical characteristics of patients with ID, IDA, or ILE and applied MCV, MCVr, and CHr as diagnostic variables were considered eligible for meta‐analysis. English‐language studies published between 2004 and 2024 were considered. No relevant systematic reviews on this topic were found. Prospective/retrospective cohort, case–control, and cross‐sectional studies were deemed suitable for the meta‐analysis (Figure 1).
FIGURE 1.

Flow diagram for inclusion of studies in the combined systematic review and meta‐analysis. Source: Moher et al. [25].
2.3. Study Selection
In the initial screening phase, titles and abstracts were examined to identify potentially relevant studies, followed by a more detailed evaluation of the selected studies. The selection of studies was carried out based on specific inclusion and exclusion criteria. Additionally, duplicate records, review articles, case reports, expert opinions, letters, and editorials were excluded from the review process. Additionally, studies that included only human subjects or used MCV, MCVr, and CHr as biomarkers unrelated to ID, IDA, and ILE were excluded. Articles without accessible numerical data (gray literature), those published in languages other than English, and studies focusing solely on ID, IDA, and ILE were removed from consideration (Table 1). Given the study's objective of examining changes in the MCVr and CHr indices in dogs and cats affected by ILE, observational studies (cohort, case–control, and cross‐sectional) were selected for inclusion in the review. These study designs provide appropriate comparative data between animals with ILE (as the exposure group) and healthy animals (the control group), making them more suitable for assessing these indices in animals affected by ILE. Since the aim was not to investigate the effect of a therapeutic intervention, clinical trials and interventional studies were excluded from the analysis. In total, the eight included studies comprised 316 dogs and 329 cats, providing a combined sample size of 645 animals. The smallest sample size was reported in Fry and Kirk [16] with only 7 cases, while the largest belonged to Keiner et al. [8] with 245 cases.
TABLE 1.
Selection criteria used to include or exclude articles.
| Inclusion criteria | Exclusion criteria |
|---|---|
| English language articles | Non‐English language articles |
| Original/research articles | Review articles and Human studies |
| Articles with numerical data | Articles with no numerical data or gray literatures |
| Studies with control groups | Studies not including control groups |
| Studies focusing on ID or ILE and MCV, MCVr, CHr in dogs and cats | Studies focusing solely on ID or ILE in dogs and cats |
Abbreviations: CHr, reticulocyte hemoglobin content; ID, iron deficiency; MCVr, reticulocyte mean cell volume.
2.4. Data Extraction
The following information was systematically collected: details of the articles (including the first author and publication year), the country of study, the species involved, sex, specifications of the devices used, the status of case/control participants, and the variables investigated (Table 2). Data extraction was conducted independently and in parallel by two researchers (Y.H. and P.A.) to minimize the likelihood of errors and bias. A list of articles excluded in the eligibility stage and the reason for each removal is present in Data S1.
TABLE 2.
Characteristics of included studies: Species, analytical devices, case and control groups, and evaluated variables.
| Authors | Year | Country | Species | Device (for hematology analyses) | Case group/condition | Case group/number | Control group/condition | Control group/number | Researched variables |
|---|---|---|---|---|---|---|---|---|---|
| Fry and Kirk | 2006 | United States | Dog | ADVIA 120 | Nutritional ID | 7 | Healthy | 7 | CHr, MCVr, MCV |
| Radakovich et al. | 2015 | United States | Dog | ADVIA 120 | Low CHr | 47 | Normal CHr | 49 | CHr, MCVr, MCV |
| Schaefer and Stokol | 2015 | United States | Dog | ADVIA 2120 | FeDef | 11 | Healthy | 122 | CHr, MCVr, MCV |
| Melendez‐Lazo et al. | 2015 | Spain | Dog | ADVIA 120 | Non‐regenerative Anemia | 24 | Healthy | 16 | CHr, MCVr |
| Foy et al. | 2015 | United States | Dog | ADVIA 120 | Blood Donors | 13 | Non‐donors | 20 | CHr, MCVr, MCV |
| Hunt and Jugan | 2021 | United States | Cat | ADVIA 2120i | Decreased Serum Iron | 7 | Normal Serum Iron | 13 | CHr, MCVr, MCV |
| Keiner et al. | 2020 | Germany | Cat | ADVIA 2120 | ILE | 20 | Non‐ILE | 225 | CHr, MCV |
| Betting et al. | 2022 | Switzerland | Cat | ADVIA 2120i | ID | 9 | Non‐ID | 55 | CHr, MCVr, MCV |
Abbreviations: CHr, reticulocyte hemoglobin content; FeDef, Fe deficiency; ID, iron deficiency; ILE, iron‐limited erythropoiesis; MCV, mean corpuscular volume; MCVr, reticulocyte mean cell volume.
2.5. Data Analysis
To enable a comparison of results from different studies, which recorded different measurement scales, and to limit any possible influence posed by measuring small sample sizes, all effect sizes were transformed into Hedges' g. It is assumed that this standardized index is a modification of Cohen's d, an unbiased measure of effect size achieved by applying a correction factor; this is of great advantage for small sample sizes. This transformation enables us to combine the results of various studies and present them in a manner that facilitates interpretation and understanding. Effect size measures tell us how much one group differs from another. There are many methods to calculate it; one of the most well‐known is Cohen's d method. Cohen's d is the difference between two means divided by the standard deviation of the data. Cohen's d and Hedges' g are remarkably similar measures of effect size, except when sample sizes are below 20; in this case, Hedges' g is a corrected effect size. For sample sizes greater than 20, the results for both statistics are roughly equivalent. Funnel and forest plots are the most popular graphical representations for meta‐analysis results. Funnel plots provide a proper graphical representation of the presence of bias, and forest plots represent the heterogeneity of findings within studies included in a meta‐analysis. A meta‐analysis was performed in Stata 14, using the “meta” command to pool the effect size estimates with the random effects method. A forest plot was generated for each analysis. Publication bias was assessed using a funnel plot plotted against the data, and heterogeneity was assessed by the I‐squared index, in which values greater than 50 were considered heterogeneous. However, due to data limitations, a systematic risk of bias assessment was not performed in individual studies using standardized tools such as the Newcastle–Ottawa Scale, which constitutes a limitation of this meta‐analysis. Data obtained from dogs and cats were separately included in subgroup analyses. To better examine and control the heterogeneity resulting from the combination of different species (dog and cat) and various variables (MCV, MCVr, CHr), we created separate forest plots for each species and each variable. This disaggregated analysis is essentially a subgroup analysis of the species and variables, allowing us to investigate the specific effects of each group separately and avoid the influence of heterogeneous combined activity.
3. Results
3.1. Assessment of MCV, MCVr, and CHr in Dogs and Cats With ILE
Using a random‐effects model, the I 2 values for MCV, MCVr, and CHr were 95.4%, 93.9%, and 97.6%, respectively, in dogs and cats (Figure 2), indicating high heterogeneity among the included articles (p < 0.001). We used a funnel plot with pseudo 95% confidence limits and a scatterplot to visualize the effect size of interest against the measure of study precision, represented by the standard error of the effect size. The funnel plot is used primarily as a visual aid for detecting publication bias. An asymmetric inverted funnel shape arises from a “well‐behaved” dataset in which publication bias is unlikely. Figure 3 shows that this symmetry cannot be attributed to the graph, mainly due to the relatively small number of retrievable articles. The random effect sizes for MCV, MCVr, and CHr are 1.98, 2.54, and 3.87, respectively. The 95% confidence intervals (CIs) for MCV vary between 0.73 and 3.22, MCVr between 1.29 and 3.78, and CHr between 1.90 and 5.85, as shown in Table 3.
FIGURE 2.

Forest plot for individual and pooled estimated (ES) amounts of effect size for the difference between the two groups with and without anemia. The vertical line shows the value of zero, and the vertical dashed line shows the value of the pooled estimate. The squares show the point estimates, and the lateral lines show the 95% confidence intervals for the estimate of each study. The diamond shows the pooled estimates' point and 95% confidence interval. Note: Weights are from random effects analysis.
FIGURE 3.

The funnel plot of MCV, MCVr, and CHr for the graphical assessment of publication bias in the meta‐analysis with pseudo 95% confidence limits. A symmetric inverted funnel shape arises from a “well‐behaved” dataset, in which publication bias is unlikely. As can be seen in this figure, this symmetry cannot be attributed to the graph, mainly due to the relatively small number of retrievable articles.
TABLE 3.
CHr, MCVr, and MCV: mean ± SD, effect size, and 95% CI in included studies.
| Included studies | CHr | MCVr | MCV | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Effect size | 95% CI | Mean ± SD | Effect size | 95% CI | Mean ± SD | Effect size | 95% CI | |
| Fry (2006, dog) | |||||||||
| ID (n = 7) | 19.50 ± 2.20 | 4.01 | 2.19–5.83 | 71.30 ± 5.30 | 3.72 | 1.99–5.45 | 65.50 ± 2.30 | 2.13 | 0.82–3.44 |
| Control (n = 7) | 25.80 ± 0.30 | 86.40 ± 2.20 | 69.90 ± 1.80 | ||||||
| Radakovic (2015, dog) | |||||||||
| ID (n = 47) | 21.25 ± 0.80 | 5.23 | 4.38–6.07 | 79.50 ± 5.16 | 2.23 | 1.72–2.74 | 63.00 ± 2.80 | 1.53 | 1.07–1.99 |
| Control (n = 49) | 25.20 ± 0.71 | 92.00 ± 6.00 | 68.00 ± 3.65 | ||||||
| Schaefer (2015, dog) | |||||||||
| ID (n = 11) | 16.82 ± 1.05 | 11.89 | 10.33–13.45 | 73.45 ± 5.33 | 4.08 | 3.29–4.87 | 58.40 ± 5.40 | 7.00 | 5.96–8.04 |
| Control (n = 122) | 26.70 ± 0.81 | 88.30 ± 3.46 | 69.60 ± 0.60 | ||||||
| Melendez‐Lazo (2015, dog) | |||||||||
| ID (n = 24) | 24.50 ± 3.40 | 0.22 | −0.41 to 0.85 | 84.80 ± 7.55 | 0.13 | −0.50 to 0.76 | — | — | — |
| Control (n = 16) | 25.10 ± 1.18 | 83.90 ± 5.62 | — | ||||||
| Foy (2015, dog) | |||||||||
| ID (n = 13) | 24.60 ± 0.58 | 2.49 | 1.57–3.41 | 88.80 ± 2.01 | 1.09 | 0.34–1.83 | 67.40 ± 1.03 | 0.87 | 0.14–1.60 |
| Control (n = 20) | 25.90 ± 0.48 | 90.80 ± 1.71 | 68.60 ± 1.56 | ||||||
| Total (random effects) | |||||||||
| ID (n = 102) | 4.73 | 1.37–8.08 | 2.18 | 0.87–3.58 | 2.86 | 0.55–5.18 | |||
| Control (n = 214) | |||||||||
| Hunt (2021, cat) | |||||||||
| ID (n = 7) | 16.70 ± 0.83 | 1.56 | 0.53–2.60 | 55.00 ± 4.16 | 1.94 | 0.84–3.03 | 45.00 ± 2.50 | 0.46 | −0.47 to 1.39 |
| Control (n = 13) | 18.00 ± 0.83 | 62.00 ± 3.30 | 46.00 ± 2.00 | ||||||
| Keiner (2020, Cat) | |||||||||
| ID (n = 20) | 14.69 ± 1.57 | 1.07 | 0.61–1.54 | — | — | — | 39.80 ± 3.08 | 0.56 | 0.10–1.02 |
| Control (n = 225) | 16.49 ± 1.68 | — | 43.45 ± 6.70 | ||||||
| Betting (2022, cat) | |||||||||
| ID (n = 9) | 15.60 ± 0.53 | 5.01 | 3.89–6.12 | 51.40 ± 1.73 | 4.96 | 3.85–6.07 | 42.10 ± 0.71 | 1.56 | 0.80–2.31 |
| Control (n = 55) | 17.70 ± 0.40 | 57.00 ± 1.01 | 43.10 ± 0.63 | ||||||
| Total (random effects) | |||||||||
| ID (n = 36) | 2.51 | 0.29–4.74 | 3.45 | 0.49–6.41 | 0.85 | 0.19–1.51 | |||
| Control (n = 293) | |||||||||
| Overall (random effects) | |||||||||
| ID (n = 138) | 3.87 | 1.90–5.85 | 2.54 | 1.29–3.78 | 1.98 | 0.73–3.22 | |||
| Control (n = 507) | |||||||||
Abbreviations: 95% CI, 95% confidence interval; CHr, reticulocyte hemoglobin content; ID, iron deficiency; MCV, mean corpuscular volume; MCVr, reticulocyte mean cell volume; SD, standard deviation.
3.2. Assessment of MCV, MCVr, and CHr in Dogs With ILE
After thoroughly reviewing multiple sources, we identified five studies that provide relevant data on the dog's MCV, MCVr, and CHr in the presence of ILE. These studies were included in the meta‐analysis. Using a random effect model, I‐squared values of 97% (Figure 4), 94.3% (Figure 5), and 98.2% (Figure 6) were obtained for MCV, MCVr, and CHr, respectively, indicating high heterogeneity among the included articles (p < 0.001). The random effect sizes for MCV, MCVr, and CHr are 2.86, 2.18, and 4.73, respectively. The 95% CIs for MCV vary between 0.55 and 5.18, MCVr between 0.87 and 3.58, and CHr between 1.37 and 8.08, as shown in Table 3.
FIGURE 4.

Forest plot for individual and pooled ES amounts of effect size for difference of MCV between the two groups with and without anemia in cats and dogs separately. The vertical line shows the value of zero, and the vertical dashed line shows the value of the pooled estimate. The squares show the point estimates, and the lateral lines show the 95% confidence intervals for the estimate of each study. The diamond shows the pooled estimates' point and 95% confidence interval. Note: Weights are from random effects analysis.
FIGURE 5.

Forest plot for individual and pooled ES amounts of effect size for the difference of MCVr between the two groups with and without anemia in cats and dogs separately. The vertical line shows the value of zero, and the vertical dashed line shows the value of the pooled estimate. The squares show the point estimates, and the lateral lines show the 95% confidence intervals for the estimate of each study. The diamond shows the pooled estimates' point and 95% confidence interval. Note: Weights are from random effects analysis.
FIGURE 6.

Forest plot for individual and pooled ES amounts of effect size for difference of CHr between the two groups with and without anemia in cats and dogs separately. The vertical line shows the value of zero, and the vertical dashed line shows the value of the pooled estimate. The squares show the point estimates, and the lateral lines show the 95% confidence intervals for the estimate of each study. The diamond shows the pooled estimates' point and 95% confidence interval. Note: Weights are from random effects analysis.
3.3. Assessment of MCV, MCVr, and CHr in Cats With ILE
Our meta‐analysis included three studies that evaluated the cat's MCV, MCVr, and CHr in relation to ILE, which were selected following a thorough review of the relevant literature. Using a random‐effects model, the I 2 values for MCV, MCVr, and CHr were 63.1% (Figure 4), 93% (Figure 5), and 95.1% (Figure 6), respectively, indicating high heterogeneity among the included articles (p < 0.001). The random effect sizes for MCV, MCVr, and CHr are 0.85, 3.45, and 2.51, respectively. The 95% CIs for MCV vary between 0.19 and 1.5, MCVr between 0.49 and 6.41 (Figure 5) for MCVr, and CHr between 0.29 and 4.74, as shown in Table 3.
4. Discussion
At the outset, we will summarize the methods employed in each article included in this study to explain the reasoning for its incorporation into the statistical analysis. In Fry 2006, the researchers induced nutritional ID in healthy dogs [16]. They did this by feeding them an iron‐deficient diet for 35 days. The Radakovic 2015 article discussed subtracting absolute ID from functional ID [13]. It measured how inflammatory factors relate to CHr in dogs. These factors include white blood cells and acute‐phase proteins. The Schaefer 2015 study examined the usefulness of reticulocyte indices [7]. They can tell IDA apart from three other diseases in dogs. It used healthy dogs to set RIs. They selected the dogs based on a brief history and physical exam. The intervals are for important blood indices. Then, according to these RIs and many other criteria, we identified the dogs by their ID. In Melendez‐Lazo's 2015 study, he investigated the effect of inflammation on reticulocyte indices [17]. He found that inflammation causes functional ILE. A 2015 article studied the effect of blood donation on ID [18]. It used reticulocyte indices in dogs.
Dogs donating blood six or more times yearly will show signs of ID based on their reticulocyte indices. However, these changes might not appear in their biochemistry or mature RBC indices. Hunt's 2021 study aimed to determine the prevalence of ILE in cats with gastrointestinal disease [19]. The Keiner 2020 article established RIs for CHr and RETIC‐HGB in healthy cats. It then studied the usefulness of these two indices [8]. They diagnose ILE. The 2022 Betting study aims to investigate the use of reticulocyte indices [20]. They diagnose CKD and chronic hematuria. Subcutaneous ureteral bypasses relate to these.
ILE is one of the important disorders in dogs and cats, with considerable implications in small animal medicine. Furthermore, ILE can cause various problems in the body before it leads to anemia; therefore, early diagnosis and intervention in the management of this disease are of paramount importance. This deficiency occurs when tissue stores of iron deplete [26, 27], a condition that can be managed with proper nutrition and medical intervention. The reasons are insufficient dietary intake of iron, iron malabsorption, blood loss, portosystemic shunt, and any factor affecting ferritin function, such as inflammation [28, 29], which are practical issues veterinarians encounter daily.
The diagnosis of ILE involves both direct and indirect methods. Direct methods typically analyze blood serum to measure levels of key analytes, including iron, ferritin, and transferrin. Conversely, indirect methods evaluate the alterations in RBC characteristics that result from a decrease in iron levels. These characteristics include MCH, MCHC, MCV, and red cell distribution width (RDW) [27, 30, 31].
Since ILE appears in old diagnostic tests over time, reticulocyte indices have gained prominence in recent years. These can identify ILE in the earliest possible stages and prevent its consequences. The most notable reticulocyte indices, in order of preference, are CHr, MCVr, and CHCMr. Based on this prioritization, we selected articles that included CHr [12, 32]. In seven out of eight articles, MCVr was also present, but CHCMr needed to be more available.
Objective criteria revealed that the case groups in eight selected articles exhibited varying degrees of ILE. By comparing the MCV, MCVr, and CHr of these groups with those of the control groups, we found significant differences between the case and control groups. Nevertheless, further actions were taken to prove the effectiveness of these variables in characterizing ILE.
As expected in this study, MCV, MCVr, and CHr have been reduced in those groups with confirmed ILE; however, the reduction in CHr was more significant than in the other variables. Afterward, the meta‐analysis revealed that the effect size of CHr in all dog groups was more substantial than that of MCVr and MCV, as expected. Due to the magnitude of the MCVr effect size compared to other indices, when using CHr as a variable to characterize ILE, it is essential to proceed with caution. The higher MCVr effect size might be due to the following reasons: insufficient studies were available for cats, and one of the articles related to cats used in this study lacked MCVr data. We also consider MCVr a more reliable variable for characterizing ILE in cats.
Although the overall results of the combined meta‐analysis were presented, subgroup analyses were conducted for dogs and cats, as well as for each variable separately, to control for heterogeneity arising from different species and variables. The results are presented as forest plots, which facilitate a better understanding of the specific effects of species and variables. However, given the biological differences between species and the distinct nature of the measured variables, caution is needed when interpreting the results. Despite the limited number of studies, the I 2 statistic is a powerful and accepted tool for assessing and estimating the degree of heterogeneity. This enhanced the analytical power and data interpretation in the study. However, the main limitation of I‐squared is its inability to identify the causes of heterogeneity.
5. Limitations
One major limitation of this meta‐analysis is the absence of a comprehensive risk of bias assessment in the included primary studies. The only tool used was the funnel plot for evaluating publication bias; a systematic risk of bias evaluation using standardized tools, such as the Newcastle–Ottawa Scale, was not performed. Furthermore, the limited number of studies and the high heterogeneity observed (I 2 values ranging from 63% to 98%) increase the likelihood of selection and reporting biases. Therefore, the results should be interpreted with caution, and it is recommended that future research conduct more systematic evaluations of the quality and bias of the included studies to enhance the robustness of the results obtained from the meta‐analysis.
6. Conclusion
The results of this meta‐analysis indicate significant differences in these indices between groups with ILE and healthy control groups. Specifically, CHr in dogs and MCVr in cats showed the most substantial differences, which might help in monitoring this condition. Important variability among studies indicates caution in generalizing findings and makes conclusions less definitive. The current results support the view that reticulocyte indices can be valuable tools for early diagnosis and monitoring of ILE in veterinary medicine, especially in situations where traditional RBC indices have not yet changed.
Disclosure
Authors declare no off‐label use of antimicrobials.
Ethics Statement
Authors declare no institutional animal care and use committee or other approval was needed. Authors declare human ethics approval was not needed.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Data S1: Supporting Information.
Acknowledgments
This research was funded by the research project of Semnan University, Iran (Number: 1403174).
Ahmadi‐hamedani M., Mirmohammadkhani M., Kafshdouzan K., Amoozadeh P., and Heydarkhani Y., “Iron‐Limited Erythropoiesis in Dogs and Cats: A Systematic Review and Meta‐Analysis of Current Evidence Examining Mean Corpuscular Volume, Mean Reticulocyte Volume, and Reticulocyte Hemoglobin Content,” Journal of Veterinary Internal Medicine 39, no. 5 (2025): e70239, 10.1111/jvim.70239.
Funding: This work was supported by the research project of Semnan University, Iran (1403174).
References
- 1. Kılıç M., Özpınar A., Serteser M., Kilercik M., and Serdar M., “The Effect of Reticulocyte Hemoglobin Content on the Diagnosis of Iron Deficiency Anemia: A Meta‐Analysis Study,” Journal of Medical Biochemistry 41 (2022): 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Chasis J. A. and Mohandas N., “Erythroblastic Islands: Niches for Erythropoiesis,” Blood 112 (2008): 470–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Hamdi Y., “Histological Study of Erythroid Lineage in the Bone Marrow of Local Adult Goat (Caprus Hircus),” Iraqi Journal of Agricultural Sciences 49 (2018): 105–110. [Google Scholar]
- 4. Thomas C. and Thomas L., “Anemia of Chronic Disease: Pathophysiology and Laboratory Diagnosis,” Laboratory Hematology 11 (2005): 14–23. [PubMed] [Google Scholar]
- 5. Fuchs J., Moritz A., Grußendorf E., et al., “Canine Reticulocyte Hemoglobin Content (RET‐He) in Different Types of Iron‐Deficient Erythropoiesis,” Veterinary Clinical Pathology 46 (2017): 422–429. [DOI] [PubMed] [Google Scholar]
- 6. Steinberg J. D. and Olver C. S., “Hematologic and Biochemical Abnormalities Indicating Iron Deficiency Are Associated With Decreased Reticulocyte Hemoglobin Content (CHr) and Reticulocyte Volume (rMCV) in Dogs,” Veterinary Clinical Pathology 34 (2005): 23–27. [DOI] [PubMed] [Google Scholar]
- 7. Schaefer D. M. and Stokol T., “The Utility of Reticulocyte Indices in Distinguishing Iron Deficiency Anemia From Anemia of Inflammatory Disease, Portosystemic Shunting, and Breed‐Associated Microcytosis in Dogs,” Veterinary Clinical Pathology 44 (2015): 109–119. [DOI] [PubMed] [Google Scholar]
- 8. Keiner M., Fuchs J., Bauer N., and Moritz A., “Evaluation of Reticulocyte Hemoglobin Content (RETIC‐HGB) for the Diagnosis of Iron‐Limited Erythropoiesis in Cats,” Veterinary Clinical Pathology 49 (2020): 557–566. [DOI] [PubMed] [Google Scholar]
- 9. Thomas D. W., Hinchliffe R. F., Briggs C., et al., “Guideline for the Laboratory Diagnosis of Functional Iron Deficiency,” British Journal of Haematology 161 (2013): 639–648. [DOI] [PubMed] [Google Scholar]
- 10. Fuchs J., Moritz A., Grußendorf E., et al., “Evaluation of Reticulocyte Hemoglobin Content (RET‐He) in the Diagnosis of Iron‐Deficient Erythropoiesis in Dogs,” Veterinary Clinical Pathology 46 (2017): 558–568. [DOI] [PubMed] [Google Scholar]
- 11. Briggs C., “Quality Counts: New Parameters in Blood Cell Counting,” International Journal of Laboratory Hematology 31 (2009): 277–297. [DOI] [PubMed] [Google Scholar]
- 12. Moloney C., Stavroulaki E. M., and Augusto M., “Reference Intervals for Reticulocyte Indices, Immature Reticulocyte Fraction, and the Percentage of Hypochromic Red Blood Cells in Adult Large Breed Dogs Using the ADVIA 2120 Hematology Analyzer,” Veterinary Clinical Pathology 52 (2023): 755–760. [DOI] [PubMed] [Google Scholar]
- 13. Radakovich L. B., Santangelo K. S., and Olver C. S., “Reticulocyte Hemoglobin Content Does Not Differentiate True From Functional Iron Deficiency in Dogs,” Veterinary Clinical Pathology 44 (2015): 511–518. [DOI] [PubMed] [Google Scholar]
- 14. Schaefer D. M. and Stokol T., “Retrospective Study of Reticulocyte Indices as Indicators of Iron‐Restricted Erythropoiesis in Dogs With Immune‐Mediated Hemolytic Anemia,” Journal of Veterinary Diagnostic Investigation 28 (2016): 304–308. [DOI] [PubMed] [Google Scholar]
- 15. Bohn A. A., “Diagnosis of Disorders of Iron Metabolism in Dogs and Cats,” Veterinary Clinics of North America. Small Animal Practice 43 (2013): 1319–1330. [DOI] [PubMed] [Google Scholar]
- 16. Fry M. M. and Kirk C. A., “Reticulocyte Indices in a Canine Model of Nutritional Iron Deficiency,” Veterinary Clinical Pathology 35 (2006): 172–181. [DOI] [PubMed] [Google Scholar]
- 17. Meléndez‐Lazo A., Tvarijonaviciute A., Cerón J., Cerón J. J., Planellas M., and Pastor J., “Evaluation of the Relationship Between Selected Reticulocyte Parameters and Inflammation Determined by Plasma C‐Reactive Protein in Dogs,” Journal of Comparative Pathology 152 (2015): 304–312. [DOI] [PubMed] [Google Scholar]
- 18. Foy D., Friedrichs K., and Bach J., “Evaluation of Iron Deficiency Using Reticulocyte Indices in Dogs Enrolled in a Blood Donor Program,” Journal of Veterinary Internal Medicine 29 (2015): 1376–1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Hunt A. and Jugan M. C., “Anemia, Iron Deficiency, and Cobalamin Deficiency in Cats With Chronic Gastrointestinal Disease,” Journal of Veterinary Internal Medicine 35 (2021): 172–178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Betting A., Schweighauser A., and Francey T., “Diagnostic Value of Reticulocyte Indices for the Assessment of the Iron Status of Cats With Chronic Kidney Disease,” Journal of Veterinary Internal Medicine 36 (2022): 619–628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Bourgès‐Abella N., Geffré A., Concordet D., Braun J. P., and Trumel C., “Canine Reference Intervals for the Sysmex XT‐2000iV Hematology Analyzer,” Veterinary Clinical Pathology 40 (2011): 303–315. [DOI] [PubMed] [Google Scholar]
- 22. Jung J. H., Yang Y., Seo D., Cho S., Choi G., and Kim Y., “Clinical Utility of Immature Reticulocyte Fraction for Identifying Early Red Blood Cell Regeneration in Anemic Dogs,” Journal of Veterinary Internal Medicine 37 (2023): 484–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Moritz A., Fickenscher Y., Meyer K., Failing K., and Weiss D. J., “Canine and Feline Hematology Reference Values for the ADVIA 120 Hematology System,” Veterinary Clinical Pathology 33 (2004): 32–38. [DOI] [PubMed] [Google Scholar]
- 24. Prins M., Van Leeuwen M., and Teske E., “Stability and Reproducibility of ADVIA 120‐Measured Red Blood Cell and Platelet Parameters in Dogs, Cats, and Horses, and the Use of Reticulocyte Haemoglobin Content (CH(R)) in the Diagnosis of Iron Deficiency,” Tijdschrift voor Diergeneeskunde 134 (2009): 272–278. [PubMed] [Google Scholar]
- 25. Moher D., Liberati A., Tetzlaff J., Altman D. G., and The PRISMA Group , “Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: The PRISMA Statement,” PLoS Medicine 6 (2009): e1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Naigamwalla D. Z., Webb J. A., and Giger U., “Iron Deficiency Anemia,” Canadian Veterinary Journal 53 (2012): 250–256. [PMC free article] [PubMed] [Google Scholar]
- 27. McCown J. L. and Specht A. J., “Iron Homeostasis and Disorders in Dogs and Cats: A Review,” Journal of the American Animal Hospital Association 47 (2011): 151–160. [DOI] [PubMed] [Google Scholar]
- 28. Andrews N. C., “Forging a Field: The Golden Age of Iron Biology,” Blood 112 (2008): 219–230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Donovan A., Roy C. N., and Andrews N. C., “The Ins and Outs of Iron Homeostasis,” Physiology 21 (2006): 115–123. [DOI] [PubMed] [Google Scholar]
- 30. Punnonen K., Irjala K., and Rajamäki A., “Serum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency,” Blood 89 (1997): 1052–1057. [PubMed] [Google Scholar]
- 31. Meyer D., Meyer J., and Harvey J., “Evaluation of Erythrocytic Disorders,” in Veterinary Laboratory Medicine Interpretation & Diagnosis (W.B. Saunders, 1998), 43–82. [Google Scholar]
- 32. Perez‐Ecija A., Martinez C., Fernandez‐Castañer J., and Mendoza F. J., “The Immature Reticulocyte Fraction (IRF) in the Sysmex XN‐1000 V Analyzer Can Differentiate Between Causes of Regenerative and Non‐Regenerative Anemia in Dogs and Cats,” Animals 14 (2024): 349. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1: Supporting Information.
